Cite

HARVARD Citation

    Wu, L. et al. (n.d.). 230POlaparib maintenance therapy in patients (pts) with a BRCA1 and/or BRCA2 mutation (BRCAm) and newly diagnosed advanced ovarian cancer (OC): SOLO1 China cohort. Annals of oncology. p. . [Online]. 
  
Back to record